Cargando…

Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept

OBJECTIVE: To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). METHODS: We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly evaluated adult BD patient-subjects from a sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tondo, Leonardo, Miola, Alessandro, Pinna, Marco, Contu, Martina, Baldessarini, Ross J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346033/
https://www.ncbi.nlm.nih.gov/pubmed/35918560
http://dx.doi.org/10.1186/s40345-022-00268-2
_version_ 1784761557046001664
author Tondo, Leonardo
Miola, Alessandro
Pinna, Marco
Contu, Martina
Baldessarini, Ross J.
author_facet Tondo, Leonardo
Miola, Alessandro
Pinna, Marco
Contu, Martina
Baldessarini, Ross J.
author_sort Tondo, Leonardo
collection PubMed
description OBJECTIVE: To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). METHODS: We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly evaluated adult BD patient-subjects from a specialty clinic, using bivariate methods and logistic multivariable modeling. RESULTS: Factors found more among BD-2 > BD-1 cases included: [a] descriptors (more familial affective disorder, older at onset, diagnosis and first-treatment, more education, employment and higher socioeconomic status, more marriage and children, and less obesity); [b] morbidity (more general medical diagnoses, less drug abuse and smoking, more initial depression and less [hypo]mania or psychosis, longer episodes, higher intake depression and anxiety ratings, less mood-switching with antidepressants, less seasonal mood-change, greater %-time depressed and less [hypo]manic, fewer hospitalizations, more depression-predominant polarity, DMI > MDI course-pattern, and less violent suicidal behavior); [c] specific item-scores with initial HDRS(21) (higher scores for depression, guilt, suicidality, insomnia, anxiety, agitation, gastrointestinal symptoms, hypochondriasis and weight-loss, with less psychomotor retardation, depersonalization, or paranoia); and [d] treatment (less use of lithium or antipsychotics, more antidepressant and benzodiazepine treatment). CONCLUSIONS: BD-2 was characterized by more prominent and longer depressions with some hypomania and mixed-features but not mania and rarely psychosis. BD-2 subjects had higher socioeconomic and functional status but also high levels of long-term morbidity and suicidal risk. Accordingly, BD-2 is dissimilar to, but not necessarily less severe than BD-1, consistent with being distinct syndromes.
format Online
Article
Text
id pubmed-9346033
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93460332022-08-04 Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept Tondo, Leonardo Miola, Alessandro Pinna, Marco Contu, Martina Baldessarini, Ross J. Int J Bipolar Disord Research OBJECTIVE: To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). METHODS: We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly evaluated adult BD patient-subjects from a specialty clinic, using bivariate methods and logistic multivariable modeling. RESULTS: Factors found more among BD-2 > BD-1 cases included: [a] descriptors (more familial affective disorder, older at onset, diagnosis and first-treatment, more education, employment and higher socioeconomic status, more marriage and children, and less obesity); [b] morbidity (more general medical diagnoses, less drug abuse and smoking, more initial depression and less [hypo]mania or psychosis, longer episodes, higher intake depression and anxiety ratings, less mood-switching with antidepressants, less seasonal mood-change, greater %-time depressed and less [hypo]manic, fewer hospitalizations, more depression-predominant polarity, DMI > MDI course-pattern, and less violent suicidal behavior); [c] specific item-scores with initial HDRS(21) (higher scores for depression, guilt, suicidality, insomnia, anxiety, agitation, gastrointestinal symptoms, hypochondriasis and weight-loss, with less psychomotor retardation, depersonalization, or paranoia); and [d] treatment (less use of lithium or antipsychotics, more antidepressant and benzodiazepine treatment). CONCLUSIONS: BD-2 was characterized by more prominent and longer depressions with some hypomania and mixed-features but not mania and rarely psychosis. BD-2 subjects had higher socioeconomic and functional status but also high levels of long-term morbidity and suicidal risk. Accordingly, BD-2 is dissimilar to, but not necessarily less severe than BD-1, consistent with being distinct syndromes. Springer Berlin Heidelberg 2022-08-03 /pmc/articles/PMC9346033/ /pubmed/35918560 http://dx.doi.org/10.1186/s40345-022-00268-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Tondo, Leonardo
Miola, Alessandro
Pinna, Marco
Contu, Martina
Baldessarini, Ross J.
Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title_full Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title_fullStr Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title_full_unstemmed Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title_short Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept
title_sort differences between bipolar disorder types 1 and 2 support the dsm two-syndrome concept
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346033/
https://www.ncbi.nlm.nih.gov/pubmed/35918560
http://dx.doi.org/10.1186/s40345-022-00268-2
work_keys_str_mv AT tondoleonardo differencesbetweenbipolardisordertypes1and2supportthedsmtwosyndromeconcept
AT miolaalessandro differencesbetweenbipolardisordertypes1and2supportthedsmtwosyndromeconcept
AT pinnamarco differencesbetweenbipolardisordertypes1and2supportthedsmtwosyndromeconcept
AT contumartina differencesbetweenbipolardisordertypes1and2supportthedsmtwosyndromeconcept
AT baldessarinirossj differencesbetweenbipolardisordertypes1and2supportthedsmtwosyndromeconcept